Congress struggles to pass funding bills as deadline looms
Back from its abridged recess, the U.S. Senate is back to work on a set of bills to fund the majority of the federal government. While senators hope to keep their funding bills free of polarizing measures, several provisions in the House bill are being opposed by House Democrats. Additionally, President Donald Trump has threatened to veto any budget that excludes significant funding for a southern border wall. These significant hurdles may prevent Congress from funding the government before the fiscal year deadline. Read more here.
How scientists in federal agencies feel about science under Trump
Survey results published by the Union of Concerned Scientists showed that scientists in federal agencies have a wide range of opinions regarding the Trump administration’s science policies. While results show that scientists at certain agencies are worried about the White House’s influence on science-based policy decisions, sampling issues prevent the study from making broad claims about the opinions of scientists in all federal agencies. Read more here.
NIH will limit its gene therapy oversight
In a commentary published yesterday in the New England Journal of Medicine, the NIH director and the Food and Drug Administration commissioner stated that the NIH would limit its assessment of gene therapy proposals. The commentary suggests that current gene therapy regulations at the FDA are sufficient to assess risks. Read more here.
Episode 12 of “Pipettes and Politics” is available.
Episode 12 of the American Society of Biochemistry and Molecular Biology’s science policy podcast “Pipettes and Politics” is now available. In this episode, ASBMB Public Affairs Director Benjamin Corb talks with Rush Holt, chief executive officer at the American Association for the Advancement of Science, about scientists running for office. Holt describes his time as a congressional representative and how his scientific training affected his experience in Congress. Listen here.